The Protective Effect of Omeg-3 Against Carbimazole Induced Hepatotoxicity in Rats
DOI:
https://doi.org/10.55544/sjmars.4.4.7Keywords:
Carbimazole, Hepatotoxicity, Hepatoprotective effect, Liver enzymes, antioxidantsAbstract
Background: The majority of medicines can predispose liver injuries when given in overdoses or with long time such as Carbimazole which is used for treatment of thyrotoxicosis. These adverse effects could be minimized by co-administer an antioxidant agents such as Omega-3 fatty acids which can reduce hepatic cell damages and improve patient outcomes.
Objective: The aim of this study is to evaluate the protective effect of Omega-3 in reducing hepatic damage by chemicals and drugs.
Method: This study was conducted in thirty constitutive days, the animals were divided in equally numbered four groups. Control group, Carbimazole group, Omega-3 group, and Carbimazole and Omega-3 group. After the final treatment, blood was withdrawn from each animal for biochemical tests and then killed and the livers were isolated for histological studies.
Result: The result of our study indicate that Omega-3 possess potential antioxidant effect that protect body organs from oxidative stress injuries. Red blood cells return to normal value hepatic enzyme ALP was reduced significantly in the protective group (p=0.007), other enzymes were not clearly reduced by Omega-3 supplement. Histological study show that Carbimazole group show a great hepatic deterioration such as distortion of liver architecture and necrosis area, while animal group treated with Carbimazole and Omega-3 represent a hepatic tissue with an appearance like a normal tissue.
Conclusion: The findings of this study suggest that the basic mechanisms of the hepatoprotective effects of fish oil involve inhibition of oxidative stress, enhancement of cellular antioxidant defenses, and stabilization of cell membranes.
References
[1] Michałowski P, Bielicka-Daszkiewicz K. CARBIMAZOLE–SYNTHESIS AND STRUCTURAL ANALYSIS OF THE TIAMAZOLE DERIVATIVE. The Book of Articles. 2023:15.
[2] Naser H, Aziz N. The protective effect of turmeric against carbimazole induced toxicity in male rats. Archives of Razi Institute. 2022;77(6):2081.
[3] Sharfalddin AA, Hussien MA. Bivalence metal complexes of antithyroid drug carbimazole; synthesis, characterization, computational simulation, and biological studies. Journal of molecular structure. 2021;1228:129725.
[4] Anandabaskar N. Thyroid and antithyroid drugs. Introduction to Basics of Pharmacology and Toxicology: Volume 2: Essentials of Systemic Pharmacology: From Principles to Practice. 2021:675-94.
[5] Leye A, Ndour MA, Sarr NN, Diack ND, Leye YM, Faye DE. Carbimazole Drug-Induced Hepatitis during Treatment of Graves’ Disease: About Four Cases at Dakar Teaching Hospital. Open Journal of Internal Medicine. 2017;7(04):97.
[6] Tag El Din LM, El Melegy TT, El Hakeeem Hussien SA. Serum levels of anti-thyroid autoantibodies in different thyroid function status. Journal of Current Medical Research and Practice. 2021;6(3):298-304.
[7] Jain K, Chakrapani M, Smitha K. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole. Annals of African Medicine. 2010;9(2).
[8] Francis T, Francis N, Lazarus JH, Okosieme OE. Safety of antithyroid drugs in pregnancy: update and therapy implications. Expert opinion on drug safety. 2020;19(5):565-76.
[9] Shahidi F, Ambigaipalan P. Omega-3 polyunsaturated fatty acids and their health benefits. Annual review of food science and technology. 2018;9(1):345-81.
[10] Ruxton C, Reed SC, Simpson M, Millington K. The health benefits of omega‐3 polyunsaturated fatty acids: a review of the evidence. Journal of human nutrition and dietetics. 2004;17(5):449-59.
[11] Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. Journal of cardiology. 2016;67(1):22-7.
[12] Li X, Tang J, Mao Y. Incidence and risk factors of drug‐induced liver injury. Liver international. 2022;42(9):1999-2014.
[13] Björnsson ES. Global epidemiology of drug-induced liver injury (DILI). Current Hepatology Reports. 2019;18:274-9.
[14] Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D. Drug-related hepatotoxicity and acute liver failure. Journal of pediatric gastroenterology and nutrition. 2008;47(4):395-405.
[15] Heidari R, Niknahad H, Jamshidzadeh A, Abdoli N. Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clinical and molecular hepatology. 2014;20(3):237.
[16] Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH. Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study. British journal of clinical pharmacology. 2014;78(3):619-29.
[17] Aziz ND, Mosa AU, Hassan AH. A Comparative Study between Rosuvastatin and Pitavastatin Toxicity on Liver and Kidney in Albino Rats. Indian Journal of Forensic Medicine & Toxicology. 2020;14(3):2566-72.
[18] Cano P A, Cifuentes P L, Amariles P. Structured literature review of hepatic toxicity caused by medicines. Revista colombiana de Gastroenterología. 2017;32(4):337-48.
[19] Stirnimann G, Kessebohm K. Liver injury caused by drugs: an update. Swiss medical weekly. 2010;140(3738):w13080-w.
[20] Begriche K, Massart J, Robin M-A, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. Journal of hepatology. 2011;54(4):773-94.
[21] Atakisi O, Atakisi E, Ozcan A, Karapehlivan M, Kart A. Protective effect of omega-3 fatty acids on diethylnitrosamine toxicity in rats. European Review for Medical & Pharmacological Sciences. 2013;17(4).
[22] El-Ansary AK, Al-Daihan SK, El-Gezeery AR. On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups. Lipids in health and disease. 2011;10:1-10.
[23] Cheung CL, Sing CW, Tang C, Cheng V, Pirmohamed M, Choi CH, et al. HLA‐B* 38: 02: 01 predicts carbimazole/methimazole‐induced agranulocytosis. Clinical Pharmacology & Therapeutics. 2016;99(5):555-61.
[24] John NN. Study on the Assessment of Hepatotoxicity of Anti Hyperthyroid Drugs. Saudi J Med Pharm Sci. 2021;7(3):165-7.
[25] Kadhim S, Musa A, Abed Al-Kareem Z, Ubaid M, Aziz N. The analysis of the protective feature of Nigella sativa in reducing Carbimazole toxicity including liver and kidney parameters on Albino male rats. Sci J Med Res. 2018;2(5):14-8.
[26] Mosa AU, Naser IH, Khalaf B. The protective effect of boswellia against carbimazole incuced reanl and hepatic toxicity on male rats. Int J Pharm Res. 2021;13(1):1316-24.
[27] El Kalawy S, Mostafa M, Abd El Fattah L, Kamar S. Histological and immunohistochemical study of the effect of omega-3 fatty acids on ifosfamide-induced liver injury in adult male albino rat. Journal of Medical Histology. 2017;1(2):134-45.
[28] Sales ALC, Primo MG, Mello Neto RS, Mendes AVS, Furtado MM, Rocha JÉL, et al. A Preliminary Study on Hepatoprotective, Hypolipidemic and Aortic Morphometric Effects of Omega-3-Rich Fish Oil in Hypercholesterolemic Mice. Pharmaceuticals. 2024;17(1):72.
[29] Meligy FY, Hussein O, Mubarak H, Abdel MM. The possible protective role of omega 3 on liver of L thyroxine treated male albino rats. Histological and immunhistochemical study. Journal of Medical Histology. 2018;2(2):131-45.
[30] Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355-74.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stallion Journal for Multidisciplinary Associated Research Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/sjmars
editor@sjmars.com | 
+91-8874396939
